NDC 61841-180 - Ortizol Otic Solution
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61841-180
- Package NDCs from labels
- 61841-180-05
- Manufacturer
- Bayer HealthCare LLC, Consumer Care
- Effective date
- 2015-02-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ortizol Otic Solution - Bayer HealthCare LLC, Consumer Care | Bayer HealthCare LLC, Consumer Care | 2015-02-05 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61841-180-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2dc1-f424-e053-dadaa90a57ce | Ortizol-Otic Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61841-180-05 | OrtizolOtic Solution | 15 mL in 1 BOTTLE, DROPPER | LIQUID | 15 | 1 | |
| 61841-180-05 | OrtizolOtic Solution | 1 in 1 CARTON | LIQUID | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Somerset Therapeutics, LLC | 90a3853e-49d6-4536-be72-82cc875bcf74 | 2021-09-01 | Warnings, Adverse reactions | 04JA59TNSJ |
| FIRSTAR Sting Relief Pad | BENZOCAINE | JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD. | 0e491a7a-4204-439f-862d-741cbc0be9fd | 2021-07-06 | Warnings | U3RSY48JW5 |
| Decongestant PE Non Drowsy | PHENYLEPHRINE HCL | Allegiant Health | 7a3098b4-381c-4f32-97a7-87b53fd64428 | 2021-06-16 | Warnings | 04JA59TNSJ |
| phenylephrine hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Gland Pharma Limited | 6486d284-5189-4000-aa7d-67150e84a7b2 | 2021-04-14 | Warnings, Adverse reactions | 04JA59TNSJ |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 943638b7-527b-4724-a6b7-2018862396d4 | 2020-11-30 | Warnings, Adverse reactions | 04JA59TNSJ |
| Daytime Cold and Flu | ACETAMINOPHEN 325MG/ DEXTROMETHORPHAN HBR 10MG/ PHENYLEPHRINE HCL 5MG | Allegiant Health | bed5f9dc-45ea-4e90-86c6-86599b6f3861 | 2020-11-16 | Warnings | 04JA59TNSJ |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Sagent Pharmaceuticals | b3ff0d1d-6f3f-4e3c-9407-6f3bf3a61e7d | 2020-07-10 | Warnings, Adverse reactions | 04JA59TNSJ |
| Cold and Allergy | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Allegiant Health | 7af63769-fa56-4f1f-a2ad-5b4c108c8e4f | 2019-12-12 | Warnings | 04JA59TNSJ |
| Congestion Relief | IBUPROFEN, PHENYLEPHRINE HCL | Meijer Distribution Inc | 84f932b6-0aee-4cf9-b4b9-213560c42c1d | 2019-12-05 | Warnings | 04JA59TNSJ |
| Fire Out | BENZOCAINE AND MENTHOL | Randob Ltd. | 77ab634e-13d4-4f5f-87c8-73976e65a842 | 2019-04-12 | Warnings | U3RSY48JW5 |
| Cold Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Allegiant Health | 9a4c0c43-a71a-4e22-a3d5-9eb9622689a2 | 2019-01-02 | Warnings | 04JA59TNSJ |
| Pressure Pain Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Chain Drug Marketing Association | 1e54ecb3-c3c3-477a-8725-23f24e77a44b | 2018-12-31 | Warnings | 04JA59TNSJ |
| Cold Multi-Symptom Night-time | ACETAMINOPHEN,CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR AND PHENYLEPHRINE HCI | Allegiant Health | 3f020cf2-6011-4216-9b39-0b3dc5f0749c | 2018-12-26 | Warnings | 04JA59TNSJ |
| Sinus Headache PEMaximum Strength Non-Drowsy Maximum Strength Non-Drowsy | ACETAMINOPHEN AND PHENYLEPHRINE HCL | Allegiant Health | b04b96e0-d99b-48d1-b8b8-e2fdd8dd3f5f | 2018-12-21 | Warnings | 04JA59TNSJ |
| PSEUDO TIME PE | PHENYLEPHRINE HCHLORIDE | TIME CAP LABORATORIES, INC. | 3116f273-0517-4755-95cd-be3a7c0dd76b | 2018-12-14 | Warnings | 04JA59TNSJ |
| Severe Cold Head Congestion | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Marc Glassman, Inc. | 3a774544-1994-4a93-9da9-06e55b1a83c8 | 2018-12-13 | Warnings | 04JA59TNSJ |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | 04JA59TNSJ |
| Xyralid Hemorrhoidal | HEMORRHOIDAL SUPPOSITORIES | Innovus Pharmaceuticals, Inc. | 8a885822-42e7-44e0-82d6-fa967123866e | 2018-05-03 | Warnings | 04JA59TNSJ |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | 04JA59TNSJ |
| Childrens Multi-symptom Cold and Fever Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Wal-Mart Stores, Inc. | 7bf30c75-e867-4a2f-a481-702d7aa96c23 | 2018-01-08 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.